Medicines Australia says its chief executive should be on the Health Technology Assessment Review implementation group as the association pushes for continuity with the review's reference committee.
MA proposes CEO for HTA Review implementation group and wants 'continuity'
November 14, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Alterity Therapeutics reports positive topline data from Phase 2 trial of ATH434
July 28, 2025 - - Australian Biotech -
Radiopharm Theranostics receives IND approval to initiate Phase 1 study
July 28, 2025 - - Australian Biotech -
Clarity successfully completes $203 million institutional placement
July 28, 2025 - - Australian Biotech -
US and EU secure new trade agreement, but 'more to come' on pharmaceuticals
July 28, 2025 - - Latest News -
Leading stakeholders call for urgency on national genomics framework
July 28, 2025 - - Latest News -
Hepatitis Australia wants action as new analysis reveals many still missing cures
July 28, 2025 - - Latest News -
Ok for North Korea to have a say on our health responses, but not the US
July 28, 2025 - - Latest News